iQSTEL amends Series B preferred stock certificate of designation
iQSTEL Inc. filed an amended and restated certificate of designation for its Series B preferred stock on June 17, 2026, approved by stockholder vote. The amendment modifies the vot…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
iQSTEL Inc. filed an amended and restated certificate of designation for its Series B preferred stock on June 17, 2026, approved by stockholder vote. The amendment modifies the vot…
ImageneBio's Board amended and restated its 2025 Equity Incentive Plan, increasing the share reserve to approximately 2.53 million shares with annual 5% increases through 2036. The…
Groupon filed a certificate of amendment to its restated certificate of incorporation to expand protections for directors and officers under Delaware law. The amendment broadens in…
OSR Health, Inc. (formerly OSR Holdings, Inc. and originally Bellevue Life Sciences Acquisition Corp.) filed a Certificate of Revival with Delaware on June 11, 2026 to restore its …
The company filed a Certificate of Change with Nevada authorities on June 15, 2026. The filing represents a corporate administrative update but lacks substantive business impact de…
Verastem Oncology announced positive updated results from RAMP 205 evaluating avutometinib plus defactinib combined with standard chemotherapy in first-line metastatic pancreatic c…
Playboy amended its 2021 Equity and Incentive Compensation Plan, raising the overall share limit to 14,262,364 shares with automatic annual increases of up to 4% through 2031. The …
Shift4 Payments adopted an updated certificate of incorporation authorized to issue 320 million shares including 300 million Class A common shares and 20 million preferred shares. …
Avalyn Pharma announced completion of target enrollment in its Phase 2b MIST clinical trial evaluating AP01 (inhaled pirfenidone) for progressive pulmonary fibrosis, with topline r…
Elicio Therapeutics reported that three metastatic pancreatic cancer patients achieved confirmed complete responses after receiving ELI-002 7P followed by nivolumab-based therapy, …
Mira Pharmaceuticals announced submission of a Phase 2a clinical trial protocol for Ketamir-2, an oral NMDA receptor modulator, to treat chemotherapy-induced peripheral neuropathy …
The FDA agreed that uniQure's 3-year Phase I/II data for AMT-130 can serve as the primary basis for accelerated approval of the gene therapy for Huntington's disease, with BLA subm…
Big Digital Energy received formal notification from Nasdaq confirming it regained compliance with Listing Rule 5550(b)(1) by maintaining stockholders' equity above the $2.5 millio…
Ocean Capital Acquisition Corp filed audited balance sheet as of June 10, 2026 with PCAOB-registered firm. Auditors raised substantial doubt about going concern status given 12-mon…
Shareholders approved a special resolution extending the deadline for completing a business combination from the original date to June 12, 2027, with automatic redemption of public…
Equifax Inc. filed amended and restated bylaws covering shareholder meetings, board governance, committees, and officer roles. The update reflects standard corporate governance pra…
QI CPA LLC confirmed agreement with Global Technologies LTD's Item 4.01 disclosures in an 8-K filed June 16, 2026. The letter indicates a change in auditor or audit-related matter …
PricewaterhouseCoopers LLP confirmed agreement with statements made by Keel Infrastructure Corp in an 8-K filing dated June 16, 2026. The letter indicates an auditor change or simi…
Norwegian Cruise Line Holdings Ltd. filed an amended and restated 2013 Performance Incentive Plan to enhance equity compensation for employees, officers, directors and consultants.…
MiMedx Group updated its amended and restated bylaws to permit shareholders meetings via remote communication and modified special meeting procedures requiring 50% shareholder thre…